title: An extreme example of focal bone marrow involvement in acute myeloid leukemia.
authors.affiliation: Christ Church, University of Oxford, Oxford, United Kingdom.
authors.forename: Charlotte K
authors.initials: CK
authors.lastname: Brierley
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Morgan
authors.forename: Julian R
authors.initials: JR
authors.lastname: Sprague
authors.forename: Oreofe O
authors.initials: OO
authors.lastname: Odejide
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: DeAngelo
authors.forename: David P
authors.initials: DP
authors.lastname: Steensma
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology*; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D006801:Humans; D007085:Ilium / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D013249:Sternum / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D003561:Cytarabine; D003630:Daunorubicin